These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Myelin Oligodendrocyte Glycoprotein-Associated Pediatric Central Nervous System Demyelination: Clinical Course, Neuroimaging Findings, and Response to Therapy. Thulasirajah S; Pohl D; Davila-Acosta J; Venkateswaran S Neuropediatrics; 2016 Aug; 47(4):245-52. PubMed ID: 27128728 [TBL] [Abstract][Full Text] [Related]
45. [The role of myelin oligodendrocyte glycoprotein antibodies for detection of demyelinating optic neuritis]. Wei SH; Zhao Y Zhonghua Yan Ke Za Zhi; 2017 Nov; 53(11):874-877. PubMed ID: 29141393 [TBL] [Abstract][Full Text] [Related]
46. Clinical presentation of optic neuritis with autoantibodies anti-myelin oligodendrocyte glycoprotein. Ducloyer JB; Michel L; Wiertlewski S; Lebranchu P Eur J Ophthalmol; 2019 Mar; 29(2):257-261. PubMed ID: 29972029 [TBL] [Abstract][Full Text] [Related]
47. MRI features of demyelinating disease associated with anti-MOG antibodies in adults. Denève M; Biotti D; Patsoura S; Ferrier M; Meluchova Z; Mahieu L; Heran F; Vignal C; Deschamps R; Gout O; Champfleur NM; Ayrignac X; Dallière CC; Labauge P; Dulau C; Tourdias T; Dumas H; Cognard C; Brassat D; Bonneville F J Neuroradiol; 2019 Sep; 46(5):312-318. PubMed ID: 31228536 [TBL] [Abstract][Full Text] [Related]
49. Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseases. Baumann M; Hennes EM; Schanda K; Karenfort M; Kornek B; Seidl R; Diepold K; Lauffer H; Marquardt I; Strautmanis J; Syrbe S; Vieker S; Höftberger R; Reindl M; Rostásy K Mult Scler; 2016 Dec; 22(14):1821-1829. PubMed ID: 26869530 [TBL] [Abstract][Full Text] [Related]
51. Optic neuritis, encephalitis and leptomeningeal enhancement in a patient with anti-MOG antibodies: A case study. Haddad N; Roussel B; Pelcovits A; Rizvi S Mult Scler Relat Disord; 2019 Sep; 34():14-16. PubMed ID: 31226544 [TBL] [Abstract][Full Text] [Related]
52. [Clinical analysis of neuromyelitis optica spectrum disorders in childhood]. Zhou J; Zhang Y; Ji TY; Jin YW; Bao XH; Zhang YH; Xiong H; Chang XZ; Jiang YW; Wu Y Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):118-124. PubMed ID: 30695886 [No Abstract] [Full Text] [Related]
53. [A case of anti-myelin oligodendrocyte glycoprotein (MOG) and anti-N-methyl-D-aspartate (NMDA) receptor antibody-positive encephalitis with optic neuritis]. Nagata S; Nishimura Y; Mitsuo K Rinsho Shinkeigaku; 2018 Oct; 58(10):636-641. PubMed ID: 30270341 [TBL] [Abstract][Full Text] [Related]
54. Diagnostic algorithm for relapsing acquired demyelinating syndromes in children. Hacohen Y; Mankad K; Chong WK; Barkhof F; Vincent A; Lim M; Wassmer E; Ciccarelli O; Hemingway C Neurology; 2017 Jul; 89(3):269-278. PubMed ID: 28615429 [TBL] [Abstract][Full Text] [Related]
55. [Anti-myelin oligodendrocyte glycoprotein antibody-positive neurologic disease, manifested as clinical course of classical Devic's disease: A case report]. Oji S; Yamaga T; Suzuki M; Tanaka S; Fukaura H; Nomura K Rinsho Shinkeigaku; 2020 Mar; 60(3):219-222. PubMed ID: 32101847 [TBL] [Abstract][Full Text] [Related]
56. Myelin oligodendrocyte glycoprotein-antibody-associated disorder: a new inflammatory CNS demyelinating disorder. Netravathi M; Holla VV; Nalini A; Yadav R; Vengalil S; Oommen AT; Reshma SS; Kamble N; Thomas PT; Maya B; Pal PK; Mahadevan A J Neurol; 2021 Apr; 268(4):1419-1433. PubMed ID: 33188477 [TBL] [Abstract][Full Text] [Related]
57. MOG antibody-associated encephalomyelitis/encephalitis. Salama S; Khan M; Pardo S; Izbudak I; Levy M Mult Scler; 2019 Oct; 25(11):1427-1433. PubMed ID: 30907249 [TBL] [Abstract][Full Text] [Related]
58. [Clinical polymorphism of demyelinating diseases associated with MOG-antibodies]. Kotov AS; Novikova ES; Metkechekova YV Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(12):95-101. PubMed ID: 33459548 [TBL] [Abstract][Full Text] [Related]
59. Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination. Peschl P; Schanda K; Zeka B; Given K; Böhm D; Ruprecht K; Saiz A; Lutterotti A; Rostásy K; Höftberger R; Berger T; Macklin W; Lassmann H; Bradl M; Bennett JL; Reindl M J Neuroinflammation; 2017 Oct; 14(1):208. PubMed ID: 29070051 [TBL] [Abstract][Full Text] [Related]
60. Optic neuritis in the era of biomarkers. Chen JJ; Pittock SJ; Flanagan EP; Lennon VA; Bhatti MT Surv Ophthalmol; 2020; 65(1):12-17. PubMed ID: 31425702 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]